RESEARCH-USE BIOSIMILAR ANTIBODY
Cirevetmab
Monoclonal antibody · IgG2
Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator.
TARGETTGFB1 (Canine)
YMonoclonal antibody
CATALOGSC-BS-673
CATALOG NUMBERSC-BS-673
MOLECULAR WEIGHTApprox. 145.743 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator.
Cirevetmab is a recombinant research-use antibody directed against TGFB1 (Canine).